Stock ScreenerStock IdeasZen Ratings + Top AnalystsStocks With a Zen Rating of A + Top Analyst consensus of Strong Buy + Large Upside in Target Price: Nov 8, 2025The 2 best sources of winning stocks is the Zen Ratings and our analysis of Top Analysts from Wall Street. Now we have combined them together in a best of both worlds approach to find stocks with the best upside potential.
Stock ScreenerStock IdeasZen Ratings + Top Analysts
Zen Rating: A
Upside/Downside: Large Upside
Top Analysts Consensus: Strong Buy
| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| PTC | PTC INC | A | B | $20.84B | 119,792,704 | 80.33% | 19.67% | Net Selling | Net Selling |
| TPR | TAPESTRY INC | A | B | $20.22B | 204,649,752 | 96.86% | 3.14% | Net Buying | Net Buying |
| JAZZ | JAZZ PHARMACEUTICALS PLC | A | B | $8.15B | 60,765,116 | 28.85% | 71.15% | Net Selling | Net Selling |
| MOG.A | MOOG INC | A | B | $6.33B | 31,677,811 | 89.88% | 3.99% | Net Selling | Net Buying |
| SGHC | SUPER GROUP (SGHC) LTD | A | B | $5.94B | 505,728,590 | 10.68% | 0.00% | ||
| GTES | GATES INDUSTRIAL CORP PLC | A | C | $5.56B | 258,280,391 | 89.38% | 10.62% | Net Buying | |
| CALX | CALIX INC | A | A | $4.27B | 66,276,473 | 77.45% | 22.55% | Net Selling | Net Buying |
| DLO | DLOCAL LTD | A | A | $3.99B | 293,703,516 | 34.71% | 0.00% | ||
| RSI | RUSH STREET INTERACTIVE INC | A | B | $3.80B | 229,412,772 | 25.77% | 74.23% | Net Selling | Net Selling |
| TPC | TUTOR PERINI CORP | A | D | $3.55B | 52,743,248 | 48.08% | 51.92% | Net Selling | Net Selling |
| MIRM | MIRUM PHARMACEUTICALS INC | A | A | $3.40B | 50,237,647 | 51.49% | 48.51% | Net Selling | Net Buying |
| FOLD | AMICUS THERAPEUTICS INC | A | B | $2.74B | 308,239,374 | 66.49% | 33.51% | Net Selling | Net Selling |
| EXTR | EXTREME NETWORKS INC | A | C | $2.34B | 133,718,479 | 82.22% | 17.78% | Net Selling | Net Selling |
| SPNT | SIRIUSPOINT LTD | A | A | $2.26B | 116,814,640 | 64.49% | 35.51% | Net Selling | Net Buying |
| IHS | IHS HOLDING LTD | A | C | $2.15B | 335,521,000 | 37.71% | 0.00% | ||
| ARDT | ARDENT HEALTH INC | A | C | $2.07B | 143,106,447 | 46.26% | 53.74% | Net Selling | Net Selling |
| FIVN | FIVE9 INC | A | C | $1.66B | 77,262,690 | 71.92% | 28.08% | Net Selling | Net Selling |
| BLBD | BLUE BIRD CORP | A | C | $1.60B | 31,707,943 | 68.07% | 31.93% | Net Selling | Net Selling |
| BCRX | BIOCRYST PHARMACEUTICALS INC | A | A | $1.48B | 209,920,430 | 84.08% | 15.92% | Net Selling | Net Buying |
| CRTO | CRITEO SA | A | B | $1.18B | 52,549,158 | 87.82% | 11.64% | Net Selling | Net Buying |
| NRDS | NERDWALLET INC | A | C | $892.66M | 74,512,609 | 36.70% | 47.28% | Net Selling | Net Selling |
| UDMY | UDEMY INC | A | B | $759.70M | 146,376,765 | 56.19% | 43.81% | Net Selling | Net Selling |
| TBPH | THERAVANCE BIOPHARMA INC | A | C | $748.87M | 50,361,296 | 51.78% | 48.22% | Net Selling | Net Selling |
| LYTS | LSI INDUSTRIES INC | A | C | $630.08M | 30,512,222 | 72.01% | 14.35% | Net Selling | Net Selling |
| BWMN | BOWMAN CONSULTING GROUP LTD | A | C | $593.85M | 17,233,069 | 49.24% | 50.76% | Net Selling | Net Selling |
| AKBA | AKEBIA THERAPEUTICS INC | A | B | $527.90M | 262,635,836 | 41.23% | 7.72% | Net Selling | |
| KMDA | KAMADA LTD | A | A | $380.68M | 57,505,031 | 10.05% | 0.00% | ||
| EGHT | 8X8 INC | A | B | $268.65M | 136,368,843 | 69.88% | 30.12% | Net Selling | Net Selling |
| NATR | NATURES SUNSHINE PRODUCTS INC | A | A | $242.14M | 17,635,552 | 21.90% | 78.10% | Net Selling | Net Buying |
| INFU | INFUSYSTEM HOLDINGS INC | A | A | $209.26M | 20,336,183 | 25.39% | 74.61% | Net Selling | Net Selling |
| CXDO | CREXENDO INC | A | A | $207.43M | 30,731,048 | 24.16% | 48.89% | Net Selling | Net Selling |
| ELMD | ELECTROMED INC | A | B | $203.22M | 8,349,176 | 31.12% | 68.88% | Net Selling | Net Selling |
Upgrade to Premium to View More
Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More
Already have access to Premium? Sign In
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.